FDA plans to target added sugar with industry-focused reduction strategy

By Scarlett Salem, MS, MPH

The FDA plans to develop a comprehensive added sugar reduction strategy in fiscal 2026, signaling a new phase in the agency’s efforts to curb diet-related chronic disease. The initiative would focus primarily on encouraging voluntary industry action, while also exploring new labeling claims, menu disclosures, and consumer education efforts.

The strategy would build on several FDA initiatives already underway, including front-of-package nutrition labeling, implementation of the revised “healthy” nutrient content claim, and growing scrutiny of ultra-processed foods and sugar alternatives. Together, these efforts point to a broader, market-shaping approach rather than a single regulatory mandate.

This AgencyIQ analysis examines how the FDA’s added sugar strategy could take shape, how it fits into the administration’s wider nutrition agenda, and what food companies should be watching next.

Fill out the form to read the full analysis.